Skip to main content

IVISense Toxicology Fluorescent Imaging Panel

Detect drug induced liver injury (DILI) early in the drug discovery process with Revvity' IVISense™ Toxicology Fluorescent Imaging Panel.

Drug-induced liver injury (DILI) is the leading reason for termination of drug discovery research projects and is a significant concern in attrition of new drug molecules reaching phase III clinical trials. DILI can manifest in hepatocellular, cholestatic, and steatotic forms differing in the type and pattern of tissue injury, biomarker expression and inflammation in the liver lobules.

For research use only. Not for use in diagnostic procedures.

Detect drug induced liver injury (DILI) early in the drug discovery process with Revvity' IVISense™ Toxicology Fluorescent Imaging Panel.

Drug-induced liver injury (DILI) is the leading reason for termination of drug discovery research projects and is a significant concern in attrition of new drug molecules reaching phase III clinical trials. DILI can manifest in hepatocellular, cholestatic, and steatotic forms differing in the type and pattern of tissue injury, biomarker expression and inflammation in the liver lobules.

For research use only. Not for use in diagnostic procedures.

Overview

Our Toxicology Fluorescent Imaging Panel of probes allows you to image inflammation, tissue destruction, metabolic changes, and vascular leak (edema), in a manner that can be predictive of potential drug toxicity, measuring biological changes prior to overt histological signs. Our published research shows the utility of a three-probe cocktail for imaging drug-induced liver injury (Vasquez & Peterson, J Pharmacol Exp Ther 2017; 361:87-98) via a ratio of probes specifically designed to optimize liver injury signal while minimizing normal background signal in liver and kidneys. The Toxicology Panel provides an extra vial of IVISense MMP 750 FAST to allow the preparation of the cocktail.

The inclusion of probes at 680 nm and 750 nm wavelengths further offers the opportunity for multiplex imaging of appropriate probe combinations to maximize information gained from research animals.

Additional product information

Our IVISense toxicology fluorescent imaging panel includes the following five probes (6 vials)
Part number Fluorescent probe Biological target
NEV10054EX IVISense Vascular 680 (AngioSense 680EX) Vascular probe:
Leaks into sites of vascular damage or inflammation
NEV10091 IVISense Transferrin Receptor 750  (Transferrin-Vivo 750) Transferrin receptor targeted probe:
Iron metabolism marker in liver
NEV10168 x 2 IVISense MMP 750 FAST  (MMPSense 750 FAST) Pan-MMP activatable probe:
Secreted marker of stellate cells, Kupffer cells, macrophages, and neutrophils
NEV11053 IVISense Annexin-V 750 Fluorescent Probe (Annexin-Vivo) Death/apoptosis probe:
Marker on inflammatory cells; metabolic marker on tumor cells
NEV11079 IVISense Renin 680 FAST (ReninSense 680 FAST) Renin activatable probe:
Marker of tissue renin-angiotensin system activity

 

Specifications

Brand
IVISense
Imaging Modality
Fluorescence
Shipping Conditions
Shipped in Blue Ice
Therapeutic Area
Toxicology
Unit Size
1 kit containing 5 vials

Resources

Are you looking for resources, click on the resource type to explore further.

1-4 of 4 Resources
Flyer Icon
Flyer
Best practices for designing an effective in vivo fluorescence imaging study

Fluorescence molecular imaging is the visualization of cellular and biological function in vivo to gain deeper insights into...

eBook Icon
eBook
In vivo imaging solutions

Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and...

Protocol/SOP
Protocol/SOP
IVISense fluorescent imaging panels user guide
Guide Icon
Guide
IVISense fluorescent probe selector guide for oncology research

The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and...

Scroll Icon